NZ219006A - 3-(acylaminomethyl)imidazo(1,2-a)pyridines and pharmaceutical compositions containing such - Google Patents

3-(acylaminomethyl)imidazo(1,2-a)pyridines and pharmaceutical compositions containing such

Info

Publication number
NZ219006A
NZ219006A NZ219006A NZ21900687A NZ219006A NZ 219006 A NZ219006 A NZ 219006A NZ 219006 A NZ219006 A NZ 219006A NZ 21900687 A NZ21900687 A NZ 21900687A NZ 219006 A NZ219006 A NZ 219006A
Authority
NZ
New Zealand
Prior art keywords
acylaminomethyl
pyridines
imidazo
pharmaceutical compositions
compositions containing
Prior art date
Application number
NZ219006A
Inventor
P George
C Giron
J Froissant
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8600836A external-priority patent/FR2593181B1/en
Priority claimed from FR8601553A external-priority patent/FR2593818B1/en
Application filed by Synthelabo filed Critical Synthelabo
Publication of NZ219006A publication Critical patent/NZ219006A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of general formula (I) <IMAGE> in which R1 is hydrogen or an alkyl or benzyl group and R2 is an alkyl, alkenyl, phenyl or benzyl group, or else R1 and R2 form an aliphatic chain, each of X1, X2 and X3 is hydrogen or a halogen or an alkyl, methoxy, alkylthio, methylsulphonyl, trifluoromethyl, carboxyl, cyano, nitro, amino or aminocarbonyl group, and Y is hydrogen or a halogen or a methyl, trifluoromethyl, carboxyl, cyano, amino or aminocarbonyl group. Application in therapeutics.y
NZ219006A 1986-01-22 1987-01-21 3-(acylaminomethyl)imidazo(1,2-a)pyridines and pharmaceutical compositions containing such NZ219006A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8600836A FR2593181B1 (en) 1986-01-22 1986-01-22 IMIDAZO ACYLAMINOMETHYL-3 DERIVATIVES (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR8601553A FR2593818B1 (en) 1986-02-05 1986-02-05 IMIDAZO (1,2-A) PYRIDINE ACYLAMINOMETHYL-3 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
NZ219006A true NZ219006A (en) 1989-05-29

Family

ID=26224973

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ219006A NZ219006A (en) 1986-01-22 1987-01-21 3-(acylaminomethyl)imidazo(1,2-a)pyridines and pharmaceutical compositions containing such

Country Status (15)

Country Link
EP (1) EP0234970B1 (en)
KR (1) KR870007174A (en)
AT (1) ATE62687T1 (en)
AU (1) AU586065B2 (en)
CA (1) CA1263390A (en)
DE (1) DE3769333D1 (en)
DK (1) DK32287A (en)
ES (1) ES2032455T3 (en)
FI (1) FI870254A (en)
GR (1) GR3002080T3 (en)
HU (1) HU196400B (en)
IL (1) IL81334A (en)
NO (1) NO165802C (en)
NZ (1) NZ219006A (en)
PT (1) PT84161B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289371B1 (en) * 1987-03-27 1991-09-25 Synthelabo Imidazopyridine derivatives, their preparation and therapeutical use
FR2615513B1 (en) * 1987-05-21 1989-07-13 Synthelabo DERIVATIVES OF ACYLAMINOMETHYL-3 TETRAHYDRO-5,6,7,8 IMIDAZO (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE4405378A1 (en) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhesion receptor antagonists
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
KR20070084026A (en) * 2004-11-11 2007-08-24 페레르 인터내쇼날 에스.에이. IMIDAZO[1,2-a]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO
JP5774982B2 (en) * 2008-05-19 2015-09-09 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Imidazo [1,2-a] pyridine compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB991589A (en) * 1963-04-30 1965-05-12 Selvi & C Lab Bioterapico Novel [1,2-ª‡]imidazopyridines and a process for the manufacture thereof
US3408496A (en) * 1964-11-23 1968-10-29 Parametrics Inc Alpha ray excited composition analysis
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
FR2492382A1 (en) * 1980-10-22 1982-04-23 Synthelabo IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2568880B1 (en) * 1984-08-07 1986-12-12 Synthelabo IMIDAZO ACYLAMINOMETHYL-3 DERIVATIVES (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2600650B1 (en) * 1986-06-27 1988-09-09 Synthelabo PROCESS FOR THE PREPARATION OF IMIDAZOPYRIDINES AND INTERMEDIATE COMPOUNDS

Also Published As

Publication number Publication date
AU6789587A (en) 1987-07-23
NO870251L (en) 1987-07-23
PT84161B (en) 1989-07-31
HUT43064A (en) 1987-09-28
IL81334A0 (en) 1987-08-31
DK32287D0 (en) 1987-01-21
CA1263390A (en) 1989-11-28
NO165802C (en) 1991-04-10
ATE62687T1 (en) 1991-05-15
IL81334A (en) 1991-01-31
EP0234970B1 (en) 1991-04-17
GR3002080T3 (en) 1992-12-30
NO870251D0 (en) 1987-01-21
PT84161A (en) 1987-02-01
NO165802B (en) 1991-01-02
DK32287A (en) 1987-07-23
AU586065B2 (en) 1989-06-29
ES2032455T3 (en) 1993-02-16
HU196400B (en) 1988-11-28
DE3769333D1 (en) 1991-05-23
EP0234970A1 (en) 1987-09-02
FI870254A (en) 1987-07-23
FI870254A0 (en) 1987-01-21
KR870007174A (en) 1987-08-17

Similar Documents

Publication Publication Date Title
ZA864570B (en) (meth)-acrylic acid derivatives of tricyclodecanes and their use
DE69330959T2 (en) benzodiazepine derivatives
IL107869A0 (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
BG97221A (en) ORTHO SUBSTITUTED BIPHENYLAMIDINES AND BIPHENYLIZANIDINES AND ANTI-DIABETIC OR HYPOGLYCEMICAL AGENTS CONTAINING THEM
ES8404317A1 (en) N-(substituted aminoalkanoyl)heterocyclic compounds
IL76175A (en) N-substituted tricyclic oxindole carboxamides and pharmaceutical compositions containing them
NZ219006A (en) 3-(acylaminomethyl)imidazo(1,2-a)pyridines and pharmaceutical compositions containing such
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
ES8200669A1 (en) Heterocyclic carboxamidine compounds, their preparation and pharmaceutical compositions containing them.
IL70506A (en) Dextrorotatory enantiomers of phenoxypropionic acid derivatives,their preparation and their use as herbicides
ES8800220A1 (en) 2,6-dimethyl-8 alpha -pivaloylamino-9,10-didehydro-ergoline
DE3884319D1 (en) Imidazobenzodiazepines and their acid addition salts, processes and intermediates for their preparation, their use as medicaments and preparations containing them.
GR3000488T3 (en) Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments
ES8406432A1 (en) Phenoxyphenoxypropionic acids and derivatives, and their use as herbicides
IL59803A0 (en) Oxazoline and thiazoline derivatives,their preparation and pharmaceutical compositions containing them
HUT65376A (en) Process for preparing n,n&#39;,n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient